CME Group Inc.

CME Group Inc.

240.30
EUR
+2.20
(+0.92%)
10.39EPS
18.81P/E
70.50BMarket Cap
Feb 10Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.83
9.31
9.89
10.65
10.76
12.59
13.63
13.65
13.09
13.99
15.54
17.06
18.13
18.82
Basic EPS, GAAP
2.94
3.37
3.71
4.55
12
5.73
5.93
5.88
7.3
7.39
8.86
9.68
11.26
11.92
Free Cash Flow per Basic Share
3.47
3.44
4.22
4.86
4.93
6.79
6.8
7.04
6.35
8.27
9.41
10.01
11.66
11.71
Dividend per Share
1.8
4.48
4
5.3
5.89
6.28
4.75
5.9
6.11
7.34
9.01
9.97
10.94
11.33
Book Value per Share
63.37
62.37
61
60.14
66.07
72.64
73.09
73.5
76.41
74.89
74.43
73.66
80.03
73.82
Tangible Book Value per Share
-18.96
-19.25
-19.98
-20.24
-13.79
-21.19
-19.32
-18.21
-10.7
-11.28
-11.09
-11.11
-4.38
-10.17
Basic Weighted Avg Shares
333
334
336
337
339
342
357
358
358
359
359
359
360
360
Sales/Revenue/Turnover
2,936
3,113
3,327
3,595
3,645
4,309
4,868
4,884
4,690
5,019
5,579
6,130
6,521
6,773
Operating Margin (%)
55.75
56.82
59.78
61.21
63.4
60.51
53.16
54.01
56.4
60.08
61.58
64.13
64.86
65.1
Depreciation Expense
238
233
229
225
209
249
473
464
385
363
353
337
331
333
Net Income, GAAP
977
1,127
1,247
1,534
4,063
1,962
2,117
2,105
2,636
2,691
3,226
3,526
4,072
4,287
Effective Tax Rate (%)
38.91
36.38
36.27
32.94
- -
29.31
21.33
22.62
21.84
22.9
22.33
22.36
23.61
23.36
Profit Margin (%)
33.27
36.21
37.48
42.67
111.49
45.53
43.48
43.11
56.22
53.61
57.83
57.52
62.45
63.3
Working Capital
1,095
1,014
1,080
1,086
1,234
614
1,045
1,086
1,363
1,391
1,473
720
5,063
2,914
LT Debt
2,107
2,108
2,229
2,231
2,233
3,827
3,743
3,444
2,696
3,422
3,425
2,678
3,422
3,424
Total Equity
21,161
20,924
20,552
20,341
22,412
25,965
26,159
26,352
27,399
26,879
26,738
26,487
28,728
26,520
Return on Invested Capital (%)
4.13
2.57
2.08
2.49
- -
3.72
6.76
6.84
6.82
7.61
8.83
10.16
10.42
11.06
Return on Capital (%)
4.42
2.75
2.17
2.73
- -
4.18
7.49
7.48
9.13
9.21
11.08
12.15
13.55
14.47
Return on Common Equity (%)
4.59
5.36
6.01
7.5
19.01
8.12
8.13
8.03
9.74
9.77
11.87
13.07
14.67
15.81

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
3,422
3,423
3,424
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
359
362
359
Market Capitalization
99,280
108,233
80,540

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
165,359
169,001
161,631
Cash, Cash Equivalents & STI
4,542
2,515
2,276
Accounts Receivable, Net
639
936
753
Inventories
- -
- -
- -
Total Current Liabilities
160,297
165,998
158,717
Payables & Accruals
72
75
68
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.56%
1.82%
8.46%
Free Cash Flow
12.25%
11.54%
16.6%
Net Income, GAAP
21.55%
14.4%
15.5%
Sales/Revenue/Turnover
7.14%
6.09%
6.37%
Total Cash Common Dividend
12.25%
13.36%
10.56%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,488
1,533
1,584
1,525
6,130
2025
1,642
1,692
1,538
1,649
6,521
2026
1,880
1,706
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.37
2.44
2.53
2.34
9.68
2025
2.64
2.83
2.51
3.27
11.26
2026
3.25
2.89
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6.48
1.16
1.16
1.16
9.97
2025
7.14
1.27
1.27
1.27
10.94
2026
7.51
1.3
- -
- -
- -

Company Description

CEO
Terrence A. Duffy
Full Time Employees
3,875
Sector
Finance
Industry
Investment banks/Brokers
Address
20 South Wacker Drive Chicago IL United States 60606
IPO Date
Dec 6, 2002
Business
CME Group Inc. (CME) operates the world's leading derivatives marketplace, offering futures, options, cash, and over-the-counter (OTC) products across all major asset classes including interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather, and real estate; it facilitates trading via the CME Globex electronic platform, fixed-income transactions through BrokerTec, FX spot trading on EBS, and centralized clearing via CME Clearing, which acts as counterparty for exchange-traded and OTC derivatives to mitigate credit risk. Formed in 2007 through the merger of Chicago Mercantile Exchange Holdings and CBOT Holdings—with roots tracing to the Chicago Board of Trade founded in 1848—the company maintains headquarters at 20 South Wacker Drive in Chicago, Illinois, alongside key facilities in New York, London, Singapore, and other global hubs serving clients in over 150 countries. Its exchanges—Chicago Mercantile Exchange (CME), Chicago Board of Trade (CBOT), New York Mercantile Exchange (NYMEX), and Commodity Exchange (COMEX)—provide benchmark products for hedging, speculation, and asset allocation to institutional investors, corporations, traders, and individuals worldwide. Recent developments include a July 2025 ten-year extension of the exclusive Nasdaq-100 futures license with Nasdaq; October 2025 launches of options on Solana, XRP futures, 24/7 swap-based event contracts, and simplified spot-quoted futures to expand cryptocurrency, prediction markets, and retail access; a planned 2026 rollout of 24/7 cryptocurrency futures and options trading supported by Google Cloud partnership; November 2025 unveiling of a FanDuel prediction markets platform launching in December to tap 13 million retail accounts; and an April 2025 agreement with S&P Global to sell their 50/50-owned OSTTRA post-trade solutions joint venture to KKR for $3.1 billion enterprise value, enabling focus on core exchange operations.

Company News

  • CME Group's Results Were Solid, But Not Enough To Pull The Trigger On An Upgrade

  • What Will 100 Hyperliquid (HYPE) Be Worth by 2030?

  • CME CEO Terry Duffy: We're seeing a record-level of participation

  • CME Group Inc. (CME) Q3 2026 Earnings Call Transcript

  • CME Group: 3 Key Takeaways for Long-Term Investors

  • Nasdaq and Small Caps Lead Three Day Surge as Crude Slides and Blue Chips Hold Firm

  • CME Group Q3 Earnings Call Highlights

  • CME Group Q3 Earnings Surpass Estimates, Revenues Rise Y/Y

  • Compared to Estimates, CME (CME) Q3 Earnings: A Look at Key Metrics

  • CME Group (CME) Surpasses Q3 Earnings and Revenue Estimates

  • Is CME Group Inc (CME) Overvalued After Beating Q3 Earnings Estimates? GF Score: 88/100, EPS: $2.89, Revenue: $1.737 Billion

  • CME Group Inc. Reports Highest Q3 Revenue on Record for Q3 2026

  • CME Group Inc. $CME Stock Position Increased by IFP Advisors Inc

  • Fujitsu, Nagoya University, JAMSTEC and NICT develop technology to automatically optimize parameters for solar energetic particle simulations

  • A Hacker Who Stole $270 Million Is Moving It Into Tornado Cash. Can Stolen Crypto Ever Be Recovered?

  • Multicoin Just Made HYPE Its Largest Hedge Fund Holding. Is Hyperliquid a Buy After a 14% Monthly Drop?

  • CME Group Announces First Trade for Bitcoin Cash and Uniswap Futures

  • The Big 3: VRT, CME, SMCI

  • Is a Beat in the Cards for CME Group This Earnings Season?

  • CME vs. Coinbase Global: Which Financial Stock Is a Better Buy in 2026?